健择治疗非小细胞肺癌的护理.docxVIP

健择治疗非小细胞肺癌的护理  Abstract Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer-related deaths worldwide. Although there are various treatment options available, selecting the most appropriate treatment for patients with NSCLC can be challenging. In recent years, personalized treatment has emerged as an effective approach to treating NSCLC. The purpose of this paper is to review the nursing care of patients undergoing personalized treatment for NSCLC. Introduction NSCLC is a type of lung cancer that arises from the non-small cells of the lung. It accounts for about 85% of lung cancer cases and is associated with poor prognosis. The type of NSCLC is usually determined based on the microscopic appearance of the cancer cells. The three major types of NSCLC include adenocarcinomas, squamous cell carcinomas, and large cell carcinomas. Treatment options for NSCLC depend on the stage of the cancer, the patient’s overall health, and the presence of specific mutations or biomarkers. Common treatment modalities used in NSCLC management include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. However, selecting the most appropriate treatment for patients with NSCLC can be challenging, as there are multiple factors to consider. Personalized Treatment of NSCLC Personalized treatment, also known as precision medicine, is an emerging approach to cancer treatment. It involves analyzing the genetic makeup of the tumor to identify specific genetic mutations or biomarkers that can be targeted by drugs. Personalized treatment aims to maximize the effectiveness of treatment while minimizing side effects. The genetic testing process involves taking a sample of the tumor tissue and analyzing the DNA for specific mutations. The results of the genetic testing can help to identify drugs that target specific genetic mutations or biomarkers. Therefore, patients undergoing personalized treatment receive treatment that is specifically tail